Tradestie Institutional Equity Comparison Engine
ILLR vs IVF โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
IVF Overall Edge
IVF Captures Institutional Edge (3โ0 Pillars ยท 4โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to INVO Fertility, Inc. Common Stock (IVF) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, ILLR trades at N/M Forward P/E with -432.7% operating margin (-5.2% YoY revenue) versus IVF at N/M Forward P/E and -78.7% operating margin (+16.7% YoY). In options structure, ILLR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against IVF sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
IVF
ILLR N/M vs IVF N/M Fwd P/E
Growth & Margin Winner
IVF
Op Margin -432.7% vs -78.7% ยท YoY -5.2% vs +16.7%
Momentum & Technical Winner
IVF
1Y -76.1% vs +376.9% ยท 52W Pos 1% vs 49%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ILLR
NASDAQ
Triller Group Inc. Common Stock
Investment Advice
$0.18
-23.04% 1D
Market Cap
$4.7M
1M Return
-80.49%
1Y Return
-76.08%
Forward P/E
N/M
Unified AI Score
48.6 / 100
HOLD
Tech 45.0
Fund 49.0
Flow 50.0
Mom 55.0
IVF
NASDAQ
INVO Fertility, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$2.38
-8.46% 1D
Market Cap
$3.2M
1M Return
+326.83%
1Y Return
+376.95%
Forward P/E
N/M
Unified AI Score
29.8 / 100
SELL
Tech 50.0
Fund 26.0
Flow 50.0
Mom 34.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ILLR -76.08%
IVF +376.95%
Spread: +125.04 pp (IVF Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ILLR Revenue | IVF Revenue | ILLR Op. Margin | IVF Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $0M | N/A | -532.8% | IVF |
| FY2019 | N/A | $0M | N/A | -120.8% | IVF |
| FY2020 | N/A | $0M | N/A | -531.7% | IVF |
| FY2021 | $10M | $0M | -73.7% | -125.4% | ILLR |
| FY2022 | $30M | $0M | -91.2% | -1292.5% | ILLR |
| FY2023 | $50M | $0M | -79.5% | -224.0% | ILLR |
| FY2024 | $30M | $10M | -411.9% | -101.0% | IVF |
| FY2025 | $20M | $10M | -640.1% | -105.8% | IVF |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ILLR | IVF | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $4.7M | $3.2M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | 0.0x | Lower Multiple | IVF |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -5.2% | +16.7% | Higher Growth | IVF |
| Operating Margin (TTM) Profitability | -432.7% | -78.7% | Higher Margin | IVF |
| Net Profit Margin Profitability | 0.0% | -92.3% | Higher Margin | ILLR |
| Return on Equity (ROE) Capital Efficiency | 0.0% | -72.7% | Higher ROE | ILLR |
| 52-Week Range Position Momentum | 1% ($0โ$5) | 49% ($0โ$5) | Stronger Trend | IVF |
| Beta / 30D Volatility Risk Regime | -10.16ฮฒ ยท 177% Vol | -7.15ฮฒ ยท 888% Vol | Lower Realized Risk | ILLR |
| Unified Institutional Score Composite Signal | 48.6 / 100 (HOLD) | 29.8 / 100 (SELL) | Higher Composite | ILLR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ILLR vs IVF Buy Guide
ILLR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
IVF
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ILLR nor IVF registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.